Clinical Trial Update: Evaluate the Safety, Tolerability of BAT6026 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and tolerability of BAT6026 for atopic dermatitis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• BAT6026

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING